Biotech

All Articles

Vaccine and also Keytruda combo reliable in squamous cell carcinoma

.Immune checkpoint preventions are the superheroes of cancer cells treatment. Medications like Brist...

Cue Biopharma mark time J&ampJ vet as CBO-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of considerable management hirings, shooting...

Regeneron's Opdualag rival shows 57% feedback cost

.Regeneron is back with lasting follow-up for its own LAG-3 inhibitor and also PD-1 prevention combi...

AstraZeneca messages data on internal competitors to AbbVie, Pfizer ADCs

.AstraZeneca has shared an early consider the efficiency of its own internal antibody-drug conjugate...

iTeos- GSK's TIGIT superstar presents relevant remodeling

.After revealing a period 3 launch based upon favorable midstage results, iTeos and also GSK are act...

More collective FDA can easily accelerate rare condition R&ampD: document

.The FDA ought to be actually extra open and also joint to discharge a surge in approvals of rare ai...

Zenas, MBX, Bicara scalp to Nasdaq in very hot day for biotech IPOs

.It's an unusually active Friday for biotech IPOs, along with Zenas BioPharma, MBX as well as Bicara...

Atea's COVID antiviral fails to stop hospital stays in phase 3

.Atea Pharmaceuticals' antiviral has actually neglected another COVID-19 trial, however the biotech ...

Neurocrine's quote to save schizophrenia prospect neglects

.Neurocrine Biosciences' mental illness system pivot has stopped working. The biotech was actually u...

Sanofi pays $110M upfront for late-stage radioligand therapy

.Sanofi has made an overdue entry to the radioligand party, paying out one hundred million europeans...